WAVE Life Sciences (WVE) Tops Q2 EPS by 13c

WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.20), $0.13 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $22.1 million versus the consensus estimate of $7.94 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• KeyBanc Starts Mosaic (MOS) at Sector Weight